Analysis of clinicopathologic factors predicting outcome after radical prostatectomy

Cancer

Volumn 91, Issue 8, 2001, Pages 1414-1422

  Babaian, R Joseph ^a   Troncoso, Patricia ^a   Bhadkamkar, Vijaya A ^a   Johnston, Dennis A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Biochemical failure; Prostate carcinoma; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RISK; SEMINAL VESICLE; TREATMENT FAILURE;

ADULT; AGED; CARCINOMA; CHEMOTHERAPY, ADJUVANT; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035871303     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010415)91:8<1414::AID-CNCR1147>3.0.CO;2-G     Document Type: Article

References (33)

1. Impotence following radical prostatectomy: Insight into etiology and prevention
2. Identification of residual cancer in the prostate following radiation therapy: Role of transrectal ultrasound guided biopsy and prostate specific antigen
3. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence - Data from the Utah Cancer Registry
4. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes
5. Prostate-specific antigen as serum marker for adenocarcinoma of the prostate
6. Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years
7. Prostate specific antigen related to clinical status 1 to 14 years after radical retropubic prostatectomy
8. Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy?
9. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
10. Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer
11. Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy
12. The prostatic capsule: Does it exist? Its importance in the staging and treatment of prostatic carcinoma
13. Tumor volume and prostate specific antigen: Implications for early detection and defining a window of curability
14. Histologic grading and clinical staging of carcinoma of the prostate
15. Pathologic staging of prostate carcinoma
16. The significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma
17. 1992 Staging system for prostate cancer
18. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases
19. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level
20. Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term follow-up
21. Risk factors for progression in patients with prostate cancer treated with radical prostatectomy
22. Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer
23. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer
24. Biological determinants of cancer progression in men with prostate cancer
25. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate
26. Prediction of progression following radical prostatectomy
27. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels
28. Prognostic implications of a positive apical margin in radical prostatectomy specimens
29. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy
30. Prognostic significance of positive surgical margins in radical prostatectomy specimens
31. Natural history of progression after PSA elevation following radical prostatectomy